REGCO:NASDAQRegency Centers Corporation - 5.875% Series B Cumulative Redeemable Preferred Stock Analysis
Data as of 2026-05-23 - not real-time
$22.39
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Regency Centers trades at $22.39, just above its 20‑day (22.32) and 50‑day (22.16) SMAs but still below the 200‑day SMA (22.69), indicating a short‑term bullish tilt within a neutral longer‑term backdrop. The MACD line sits marginally above its signal (0.088 vs 0.075) and the histogram is positive, while the RSI at 51 confirms the market is neither overbought nor oversold. Volume is increasing, and the price is comfortably above the identified support of $21.63, giving the stock room to test the $22.82 resistance.
Fundamentally, REGCO offers an attractive 6.56% dividend yield backed by solid operating cash flow ($819 M) and free cash flow ($575 M), yet earnings per share are currently zero and debt sits at $5.25 B with a debt‑to‑equity of 73, raising questions about dividend sustainability. The price‑to‑book of 0.61 suggests the market values the company well below its book value, pointing to a potential undervaluation, while the low beta (0.27) implies limited price volatility relative to the market.
Fundamentally, REGCO offers an attractive 6.56% dividend yield backed by solid operating cash flow ($819 M) and free cash flow ($575 M), yet earnings per share are currently zero and debt sits at $5.25 B with a debt‑to‑equity of 73, raising questions about dividend sustainability. The price‑to‑book of 0.61 suggests the market values the company well below its book value, pointing to a potential undervaluation, while the low beta (0.27) implies limited price volatility relative to the market.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover and price above short‑term SMAs
- Increasing volume supporting upward momentum
- High dividend yield offering immediate income
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Elevated debt load relative to equity
- Zero EPS raising concerns on earnings sustainability
- Stable cash flow but potential pressure from retail sector trends
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Undervalued price‑to‑book ratio indicating margin of safety
- Uncertain dividend sustainability without earnings
- Low market beta and moderate volatility supporting defensive profile
Key Metrics & Analysis
Financial Health
Revenue Growth10.00%
Profit Margin33.11%
ROE8.00%
ROA3.21%
Debt/Equity73.22
P/B Ratio0.6
Op. Cash Flow$819.4M
Free Cash Flow$574.6M
Industry P/E32.7
Technical Analysis
TrendNeutral
RSI51.4
Support$21.63
Resistance$22.82
MA 20$22.32
MA 50$22.16
MA 200$22.69
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
GradeUndervalued
TypeValue
Dividend Yield6.56%
Risk Assessment
Beta0.27
Volatility14.68%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.